Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5604]
News [13558]
Articles [218]
Editorials [5]
Conferences [266]
elearning [17]
WCLC 2026: Brain MRI surveillance without prophylactic cranial irradiation improves cognitive outcomes in small cell lung cancer
WCLC 2026: Brain MRI surveillance without prophylactic cranial irradiation improves cognitive outcomes in small...
Faecal microbiota transplantation may improve immunotherapy-related colitis
Faecal microbiota transplantation may improve immunotherapy-related colitis
WCLC 2026: Investigator presents final PAPILLON trial results showing long-term survival in a subset of lung cancer
WCLC 2026: Investigator presents final PAPILLON trial results showing long-term survival in a subset of lung cancer
WCLC 2026: Early cranial radiotherapy may improve outcomes for patients with EGFR-mutant NSCLC and limited brain metastases
WCLC 2026: Early cranial radiotherapy may improve outcomes for patients with EGFR-mutant NSCLC and limited brain...
WCLC 2026: Investigational immunotherapy nearly doubles overall survival compared with docetaxel in advanced squamous NSCLC
WCLC 2026: Investigational immunotherapy nearly doubles overall survival compared with docetaxel in advanced...
WCLC 2026: Study identifies distinct outcomes and genomic features in NSCLC with class II and III BRAF alterations
WCLC 2026: Study identifies distinct outcomes and genomic features in NSCLC with class II and III BRAF alterations
WCLC 2026: Analysis shows ivonescimab significantly improves overall survival versus pembrolizumab in PD-L1-positive advanced NSCLC
WCLC 2026: Analysis shows ivonescimab significantly improves overall survival versus pembrolizumab in PD-L1...
WCLC 2026: Trial shows risvutatug rezetecan significantly improves overall survival in relapsed small-cell lung cancer
WCLC 2026: Trial shows risvutatug rezetecan significantly improves overall survival in relapsed small-cell lung...
WCLC 2026: Trial shows Tam-Peli significantly improves survival in relapsed small-cell lung cancer
WCLC 2026: Trial shows Tam-Peli significantly improves survival in relapsed small-cell lung cancer
WCLC 2026: Zipalertinib plus chemotherapy significantly extends progression-free survival in first-line EGFR exon 20 insertion-positive NSCLC
WCLC 2026: Zipalertinib plus chemotherapy significantly extends progression-free survival in first-line EGFR exon...

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation